Constarium
← Search

Data · dataset · 2026

A serum-stable antimicrobial peptide-based delivery platform for selective treatment of non-targetable and chemo-resistant tumours

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32641962.v1

Antibody–drug conjugates have transformed cancer therapy but remain limited by their dependence on internalizing antigens, poor applicability to untargetable tumours, and susceptibility to drug resistance.

Description

Therefore, a modular antimicrobial peptide (AMP)-based therapeutic system, conjugate 270, was presented, which integrates three optimized components: a selectivity-enhanced AMP core via a membrane affinity reconstruction strategy, a conformation-driven PEGylated blocker to minimize off-target effects, and an N-terminal cap to improve stability in human serum.

By targeting non-endocytic membrane surface receptors via small-molecule ligands, conjugate 270 exhibited potent and selective cytotoxicity against target tumour cells, effectively eliminating the majority of tumour cells within a few hours. Meanwhile, it exhibited high serum stability, minimal haemolysis, and negligible cytotoxicity toward normal cells at therapeutic concentrations. Mechanistic studies confirmed ligand-dependent membrane localization, rapid depolarization and disruption, along with mitochondrial dysfunction.

Read the rest (1 more)

Moreover, it demonstrated significant therapeutic efficacy against four cell lines resistant to conventional chemotherapeutic agents. While additional in vivo validation is warranted, this work lays the foundation for a flexible AMP-based approach to address conventional untargetable and drug-resistant cancers.<br><br><i>Thesis is embargoed until 31 December 2030.</i>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75%
Provenance · 3 source records, 12 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/326419629 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/326419629 d agoJSON v1
DMU Figshareoai:figshare.com:article/326419629 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:medicine-healthmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title